202 related articles for article (PubMed ID: 17275887)
21. Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
Karandashova S; Florova G; Azghani AO; Komissarov AA; Koenig K; Tucker TA; Allen TC; Stewart K; Tvinnereim A; Idell S
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):44-52. PubMed ID: 23002099
[TBL] [Abstract][Full Text] [Related]
22. Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells.
Chung CL; Sheu JR; Liu HE; Chang SC; Chou YC; Chen WL; Chou DS; Hsiao G
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):692-700. PubMed ID: 18978303
[TBL] [Abstract][Full Text] [Related]
23. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.
Higazi AA; Bdeir K; Hiss E; Arad S; Kuo A; Barghouti I; Cines DB
Blood; 1998 Sep; 92(6):2075-83. PubMed ID: 9731065
[TBL] [Abstract][Full Text] [Related]
24. The pathogenesis of pleural space loculation and fibrosis.
Idell S
Curr Opin Pulm Med; 2008 Jul; 14(4):310-5. PubMed ID: 18520264
[TBL] [Abstract][Full Text] [Related]
25. Abnormalities of pathways of fibrin turnover in the human pleural space.
Idell S; Girard W; Koenig KB; McLarty J; Fair DS
Am Rev Respir Dis; 1991 Jul; 144(1):187-94. PubMed ID: 2064128
[TBL] [Abstract][Full Text] [Related]
26. Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema.
Florova G; Girard RA; Azghani AO; Sarva K; Buchanan A; Karandashova S; DeVera CJ; Morris D; Chamiso M; Koenig K; Cines DB; Idell S; Komissarov AA
Physiol Rep; 2021 May; 9(9):e14861. PubMed ID: 33991465
[TBL] [Abstract][Full Text] [Related]
27. Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Shetty S; Velusamy T; Shetty RS; Marudamuthu AS; Shetty SK; Florova G; Tucker T; Koenig K; Shetty P; Bhandary YP; Idell S
Am J Respir Cell Mol Biol; 2010 Sep; 43(3):358-67. PubMed ID: 19855086
[TBL] [Abstract][Full Text] [Related]
28. Design and evaluation of a thrombin-activable plasminogen activator.
Yang WP; Goldstein J; Procyk R; Matsueda GR; Shaw SY
Biochemistry; 1994 Mar; 33(8):p606-12. PubMed ID: 8117652
[TBL] [Abstract][Full Text] [Related]
29. Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator.
Schenk-Braat EA; Morser J; Rijken DC
Eur J Biochem; 2001 Nov; 268(21):5562-9. PubMed ID: 11683879
[TBL] [Abstract][Full Text] [Related]
30. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
31. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
32. Effects of TGF-beta and TNF-alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial cells.
Idell S; Kumar A; Zwieb C; Holiday D; Koenig KB; Johnson AR
Am J Physiol; 1994 Dec; 267(6 Pt 1):L693-703. PubMed ID: 7810674
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity.
Higazi AA; Ajawi F; Akkawi S; Hess E; Kuo A; Cines DB
Blood; 2005 Feb; 105(3):1021-8. PubMed ID: 15353482
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
35. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
[TBL] [Abstract][Full Text] [Related]
36. Thrombin Upregulates PAI-1 and Mesothelial-Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis.
Hsieh CY; Sheu JR; Yang CH; Chen WL; Tsai JH; Chung CL
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614900
[TBL] [Abstract][Full Text] [Related]
37. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
38. Human single-chain urokinase is activated by the omptins PgtE of Salmonella enterica and Pla of Yersinia pestis despite mutations of active site residues.
Järvinen HM; Laakkonen L; Haiko J; Johansson T; Juuti K; Suomalainen M; Buchrieser C; Kalkkinen N; Korhonen TK
Mol Microbiol; 2013 Aug; 89(3):507-17. PubMed ID: 23763588
[TBL] [Abstract][Full Text] [Related]
39. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
40. A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase.
Charpie JR; Runge MS; Matsueda GR; Haber E
Biochemistry; 1990 Jul; 29(27):6374-8. PubMed ID: 1698452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
